[Federal Register: March 19, 2008 (Volume 73, Number 54)]
[Notices]
[Page 14822-14823]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19mr08-63]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Board Meeting Times and Dates: 8:30 a.m.-5 p.m., April 7, 2008.
8:30 a.m.-5 p.m., April 8, 2008. 8:30 a.m.-3 p.m., April 9, 2008.
Public Comment Times and Dates: 5 p.m.-6 p.m., April 7, 2008.
7:30 p.m.-8:30 p.m., April 8, 2008.
Place: Crowne Plaza Tampa East, 10221 Princess Palm Avenue,
Tampa, FL 33610, Telephone (813) 623-6363, Fax (813) 246-7113.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC.
NIOSH implements this responsibility for CDC. The charter was
issued on August 3, 2001, renewed at appropriate intervals, and will
expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and
[[Page 14823]]
on whether there is reasonable likelihood that such radiation doses
may have endangered the health of members of this class.
Matters to be Discussed: The topics for the Subcommittee meeting
will include a Review of Individual Dose Reconstructions and future
Subcommittee Plans and Actions. The agenda for the Advisory Board
meeting includes: NIOSH Program Status Report Update; Special
Exposure Class (SEC) Petition Evaluation Reports for: Texas City
Chemicals, Inc., SAM Laboratories, Kellex/Pierpont, Massachusetts
Institute of Technology, Area IV of the Santa Susana Field
Laboratory, Horizons, Inc., and NUMEC Parks; Quality assurance and
quality control processes by NIOSH; Ethics training for Board
members; Procedures Work Group: summary report and full presentation
on new matrix format; SEC Petition Status Updates: Sandia National
Laboratory-Livermore, Chapman Valve, Hanford, Blockson, Bethlehem
Steel; Department of Labor (DOL) Update; Department of Energy (DOE)
Update; Work Group reports; Subcommittee on Dose Reconstruction
Report; Board Future Plans and Schedules.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted according the policy provided below. Any written
comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the
meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment), (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comment; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
Contact Person for More Information: Christine Branche, PhD,
Executive Secretary, NIOSH, CDC, 395 E Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513) 533-6800, Toll Free 1-(800)
35-NIOSH, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 12, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-5496 Filed 3-18-08; 8:45 am]
BILLING CODE 4163-18-P